APA (7th ed.) Citation

CC, T., KH, L., M, R., D, C., J, A., AG, S., . . . J, K. (2012). Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapy. Oncology reports, 27(5), 1580. https://doi.org/10.3892/or.2012.1679

Chicago Style (17th ed.) Citation

CC, Tong, et al. "Prognostic Significance of P16 in Locoregionally Advanced Head and Neck Cancer Treated with Concurrent 5-fluorouracil, Hydroxyurea, Cetuximab and Intensity-modulated Radiation Therapy." Oncology Reports 27, no. 5 (2012): 1580. https://doi.org/10.3892/or.2012.1679.

MLA (9th ed.) Citation

CC, Tong, et al. "Prognostic Significance of P16 in Locoregionally Advanced Head and Neck Cancer Treated with Concurrent 5-fluorouracil, Hydroxyurea, Cetuximab and Intensity-modulated Radiation Therapy." Oncology Reports, vol. 27, no. 5, 2012, p. 1580, https://doi.org/10.3892/or.2012.1679.